A Pilot Study Evaluating the Safety and Effectiveness of a New Pleural Catheter for the Medical Management of Symptomatic, Recurrent, Malignant Pleural Effusions
The purpose of this study is to determine whether a new catheter is safe and effective in treating malignant pleural effusions.
Malignant Pleural Effusions
DEVICE: New Indwelling Pleural Catheter
Device -related safety and the number of adverse events., 28 days post catheter insertion
pleurodesis success, Assessed by chest x-ray, thorachic ultrasound, and confirmation the catheter is patent., 14 days|Pleurodesis success, Assessed by chest x-ray, thoracic ultrasound and confirmaiton the catheter is patent., 28 days|pleurodesis success, Assessed by chest x-ray, thoracic ultrasound and confirmaiton the catheter is patent., 60 days
Breathlesness, 14, 28, 60 days|Chest Pain, 14, 28, 60 days|Time to pleurodesis, 14, 28, 60 days|Quality of Life, 14, 28, 60 days|Need for further pleural intervention post catheter removal, 60 days
The purpose of this study is to determine whether a new catheter is safe and effective in treating malignant pleural effusions.